# Stoke Therapeutics, Inc.: Form 8-K, filed Jun 30, 2026

- Company: [Stoke Therapeutics, Inc.](/companies/stok.md) (CIK 1623526)
- Form: 8-K
- Filed: 2026-06-30
- Accepted by EDGAR: Jun 30, 2026, 08:02 ET
- Period: 2026-06-30
- Accession: 0001193125-26-289409
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1623526/000119312526289409/d924679d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1623526/000119312526289409/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1623526/000119312526289409/d924679d8k.htm

Filed Jun 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-289409. Last ingested by Listed: Nov 5, 2026, 14:02 ET. No prices; not investment advice.